In our March issue of Pharmaceutical Executive
FEATURES
Cover Story
Pharma: Meet Your Neighbors
Lisa Henderson
Executives from diagnostics, payer, pharma, and patient care companies converge to share the inside scoop on outcomes-based contracting. |
Outcomes-Based Healthcare
The Quest to Measure Up
Michelle Maskaly
Outcomes-based healthcare continues to gain traction as a potential game changer. But several strategic and operational challenges are still preventing the model from becoming a mainstay. |
ADVERTISEMENT
CRO Consolidation: A Sinister Threat or Windfall for Pharma?
Live Webcast: Tuesday, March 27 at 1:00pm EDT
 Register now |
Outcomes-Based Healthcare
Risk Sharing, Italian Style
Julian Upton
Amid contrasting views on the success of the now well-established system of outcomes-based agreements in Italy, further demands on global healthcare budgets will likely point to their adoption on a wider scale. |
ADVERTISEMENT
Using Artificial Intelligence to Drive Innovation in the Life Sciences
Live Webcast: Thursday, March 22 at 1:00pm EDT
 Register now |
Interview
Markus Warmuth: A Bold Path Etched in DNA
Michael Christel
Markus Warmuth, CEO of cancer genomics company H3 Biomedicine, speaks with Pharm Exec about being part of a new wave of biotech business leaders, who let the science chart the course. |
Pricing
Pricing Turning Point: The Case for Innovating Pharma’s Model
Juan F. Rivera and Caitlyn Macdonald
Drawing from implementation lessons and successes in other industries, possible strategy shifts to pharma's pricing playbook are explored. |
|
ALSO IN THIS ISSUE
The Law of Unintended Consequences
Lisa Henderson
Tackling some of the unintended consequences associated with value-based contracting in pharma and efforts to advance toward sustainable outcomes-based engagement …Read more
Full Disclosure Demanded for Pharma Industry
Jill Wechsler
The public and policymakers seek more transparency in pricing and product development …Read more
Showdown Nears on European Research Incentives
Reflector
In the coming weeks, the EU will decide if the degree of protection offered to drug firms by research incentives such as the SPC are really in the interests of patients and society.…Read more
Setting the Standard
Michelle Maskaly
How one pharma vet helped create the first industry-wide training standards for aspiring medical affairs professionals …Read more
|
| |
| WEBCASTS |
| The Changing Market for Drugs to Treat Orphan Diseases |
| Through the Patient’s Eyes — Needs, Behaviors and the Science Behind It All |
Unlocking the Patient Voice: How Digital Technology Can Facilitate Effective Patient Data Capture in Real-World Data Programs
|
Regenerative Medicine: Overcoming Obstacles to Reimbursement and Market Access
|
Patient Centricity: Turning Rhetoric into Reality
|
Biologics Manufacturing – Is Your Company Ready?
|
Value-Based Engagement Models: Making Collaborations between Pharma and Health Systems Work
|
